Second primary melanomas on treatment with vemurafenib.
S
S
Dalle
N
N
Poulalhon
S
S
Debarbieux
L
L
Thomas
D003875:Drug Eruptions / Q000209:etiology*; D006801:Humans; D007211:Indoles / Q000009:adverse effects*; D008545:Melanoma / Q000188:drug therapy*; D047428:Protein Kinase Inhibitors / Q000009:adverse effects*; D048493:Proto-Oncogene Proteins B-raf / Q000037:antagonists & inhibitors*; D012878:Skin Neoplasms / Q000188:drug therapy*; D013449:Sulfonamides / Q000009:adverse effects*
D007211:Indoles; D047428:Protein Kinase Inhibitors; D013449:Sulfonamides; D048493:Proto-Oncogene Proteins B-raf